Figure 1

Cytotoxicity induced by γCdcPLI in breast cells by MTT cytotoxicity assay. Breast cancer cells (MDA-MB-231 and MCF-7), Lung cancer cell (A549), Prostate cancer cell (PC3), Cervix cancer cell (HeLa) and the non-tumorigenic breast cells (MCF 10A) were treated with γCdcPLI (50, 25, 12.5, 6.25, 3.125 or 1.56 µg/mL) for 24 h. All data are expressed as mean ± S.E.M and procedures were carried out in triplicate; statistically significant, ***p < 0.001, treatments compared to control (MCF 10A).